Adenosine Monophosphate Activated Kinase (AMPK) the Breakthrough Target for Metabolic Syndrome
Journal Title: Scholars Journal of Applied Medical Sciences - Year 2014, Vol 2, Issue 3
Abstract
Abstract: Metabolic syndrome is the challenging condition in current scenario in developing countries. To overcome it, the best target identification is the most challenging task. The enzyme Adenosine Monophosphate Activated Protein Kinase (AMPK) could be one of the targets to battle against such intricate conditions. The Adenosine Monophosphate Activated Protein Kinase (AMPK), a heterotrimeric serine/threonine protein kinase. Activated AMPK switches cells from an anabolic to a catabolic state, shutting down the ATP-consuming synthetic pathways and restoring energy balance, regulates key metabolic enzymes to reduce the activity of ATP-utilizing biosynthetic pathways and increase the activity of ATP-generating pathway. The fuel-sensing enzyme 5'-AMP-activated protein kinase (AMPK) has a major role in the regulation of cellular lipid and protein metabolism in response to stimuli such as exercise, changes in fuel availability and the adipocyte-derived hormones leptin and adiponectin. Abnormalities in cellular lipid metabolism are involved in the pathogenesis of the metabolic syndrome, possibly because of dysregulation of AMPK and Malonyl-CoA.It is now recognized that pharmacological activation of AMPK improves blood glucose homeostasis, lipid profile and blood pressure in insulin-resistant conditions. Indeed, AMPK activation mimics the beneficial effects of physical activity or those of calorie restriction by acting on multiple cellular targets. In addition, AMPK is one of the probable targets of major antidiabetic drugs including, the biguanides (metformin) and thiazolidinedione, as well as of insulin sensitizing adipokines (e.g., adiponectin). Taken together, such findings highlight the logic underlying the concept of targeting the AMPK pathway for the treatment of metabolic syndrome. Keywords: Metabolic syndrome, AMPK, ACC-2, HMGCo-A Reductase, CPT.
Authors and Affiliations
Abhishek B. Jha
Keywords
Related Articles
- EP ID EP374308
- DOI -
- Views 55
- Downloads 0
A Clinical Study and Management of Splenic Injury in Blunt Trauma Abdomen
Abstract: Trauma is an increasing cause of morbidity and mortality in India. Although protected under the bony ribcage, the spleen remains the most commonly affected organ in blunt injury to the abdomen in all age groups...
Biliary Merging Patterns of the Caudate Lobe: A Review Report
Concerning the previous anatomical knowledge and requirements of current hepato-pancreato-biliary practice it was our aim to enhance the anatomy knowledge of the caudate lobe biliary drainage. Using the injection-corrosi...
Morphometry of the Lumbar Vertebrae and its Clinical Significance
Abstract: Low back pain has attracted the attention of anatomists to do the measurements of lumbar vertebrae. Narrowing of all the diameters of the vertebral foramen could be responsible as a factor which might produce l...
Single Dose Pre-Operative Dexamethasone in Laparoscopic Cholecystectomy—Evaluation of Stress Markers and Post-Operative Nausea and Vomiting
Postoperative Surgical Stress, nausea and vomiting (PONV) continue to be highly undesirable outcomes of anesthesia and surgery. Therefore, multimodal approaches have been suggested in order to decrease PONV and surgical...
Study of Adenosine Deaminase (ADA) Activity in the Serum of Rheumatoid Arthritis Patients
Adenosine deaminase (ADA) is an enzyme involved in purine metabolism. It plays a significant role in the immune system. The aim of this study was to investigate the use of adenosine deaminase levels in rheumatoid arthrit...